- 01Insulin is the compensation, so it moves first
Fasting glucose and A1c only rise once your pancreas can no longer keep up. Fasting insulin rises while it still can, which is why it can flag insulin resistance years earlier, and also why it reads as a trend marker rather than a diagnosis.
Fasting insulin tells you how hard your body is working behind the scenes to keep your blood sugar normal. Your pancreas releases insulin, the hormone that moves glucose out of your blood and into your cells; when those cells respond less to its signal, the pancreas releases more. So insulin can run high for years while your fasting glucose and A1c still read perfectly normal. That makes fasting insulin an early-warning number, and a slippery one, because no lab agrees on a single normal range.
What does fasting insulin measure?
Insulin is your body's response to rising blood sugar. After you eat, glucose enters your blood, and your pancreas releases insulin to move that glucose into muscle, liver, and fat cells for fuel or storage. When those cells respond less to insulin, a state called insulin resistance, your pancreas covers the gap by making more. Fasting insulin, measured after at least 8 hours without food, captures how much insulin it takes to hold your glucose steady overnight.
That is why the number matters. A high fasting insulin sitting on top of a normal fasting glucose is a system working hard to look normal. Glucose alone shows only the result; insulin shows the effort behind it.
How does insulin resistance build, step by step?
From resistance to diabetes
The Whitehall II study followed 6,538 British civil servants, 505 of whom developed type 2 diabetes. Insulin sensitivity started slipping first, before fasting glucose climbed sharply toward the diagnosis. 2
What is HOMA-IR?
HOMA-IR stands for Homeostatic Model Assessment of Insulin Resistance. It is a single number, built from one fasting blood draw, that estimates how insulin-resistant you are by combining your fasting insulin and your fasting glucose. Matthews and colleagues published the model in 1985, and it remains the practical stand-in for the research-grade insulin clamp test, which is too involved for a clinic. 1
Say your fasting glucose is a normal-looking 95 mg/dL, but your fasting insulin is 15 microU/mL (microunits per milliliter). Your HOMA-IR is 15 times 95, divided by 405, which comes to about 3.5. That is well above the roughly 1 of an insulin-sensitive person, even though your glucose on its own looked fine.
HOMA-IR carries the same limits as fasting insulin. Thresholds differ by population and lab, there is no universal cutoff, and the American Diabetes Association (ADA) does not use HOMA-IR or fasting insulin to diagnose prediabetes or diabetes; they are risk and research measures. 3
What is a normal fasting insulin level?
There is no official answer, which frustrates people who want one clean cutoff. No major guideline sets a diagnostic range for fasting insulin, and lab assays report different reference ranges, so the same blood could read 'normal' at one lab and 'high' at another. 3 For why two labs can call the same result 'normal' and 'high', see how reference ranges work. What follows is orientation from the research literature, not a diagnosis.
| Tier | Fasting insulin (microU/mL) | HOMA-IR (approx.) | What it suggests |
|---|---|---|---|
| Insulin-sensitive (research 'optimal') | under about 8 to 10 | around 1 | cells respond well; little extra insulin needed |
| Gray zone | about 10 to 15 | about 1.5 to 2.5 | possible early insulin resistance; worth tracking as a trend |
| Likely insulin-resistant | above about 15 | above about 2.5 to 3 | pancreas working hard to keep glucose normal |
Many lab reports only flag fasting insulin as 'high' above roughly 25 microU/mL, well above the level most researchers treat as optimal. A result inside your lab's 'normal' band can still sit in the range where insulin resistance is building, which is why the trend and your other numbers matter more than a single pass or fail.
Where a fasting insulin can land (example)microU/mL
What does a high fasting insulin mean?
A high fasting insulin means your body needs a lot of insulin to keep glucose normal, the signature of insulin resistance. It tends to travel with weight around the middle, a fatty liver, PCOS (polycystic ovary syndrome), high triglycerides (blood fats) with low HDL (the protective cholesterol), and metabolic syndrome (a cluster of raised waist, blood pressure, blood sugar, triglycerides, and low HDL). Over time, sustained insulin resistance is what tips glucose upward into prediabetes and then type 2 diabetes.
A low or low-normal fasting insulin is usually a good sign, meaning your cells respond well and need little insulin. There is one exception to read carefully: a low insulin paired with a high glucose is not reassuring, because it can mean the pancreas is no longer making enough insulin, as happens in type 1 diabetes or later-stage type 2. Insulin is only interpretable next to glucose, never on its own.
How do you test for insulin resistance?
Insulin resistance has no single home test. The practical route is a fasting blood draw for insulin and glucose, from which your clinician can calculate HOMA-IR.
- Fast first. A meaningful fasting insulin needs no calories for at least 8 hours, usually drawn in the morning with your fasting glucose.
- Ask for it by name. A standard metabolic panel and A1c do not include insulin, so it is a separate order you or your clinician has to request.
- HOMA-IR needs no extra draw. It is calculated from the same fasting insulin and glucose.
- Expect to pay. Because guidelines do not use it for screening, insurance often does not cover fasting insulin, so it may be a modest out-of-pocket lab fee.
- The clamp is research only. The gold-standard measure of insulin resistance, the euglycemic-hyperinsulinemic clamp, is a multi-hour research procedure; HOMA-IR is the everyday estimate.
Fasting insulin is most informative for people who carry prediabetes risk factors: a family history of type 2 diabetes, extra weight around the middle, PCOS, high blood pressure, or high triglycerides with low HDL. If a first-degree relative has type 2 diabetes, your own risk is higher, which is worth raising with your clinician. Read fasting insulin as a trend, rechecked alongside your glucose and A1c on whatever schedule your clinician sets; the ADA already recommends at least annual glucose or A1c screening for anyone with prediabetes. 3
Fasting insulin vs fasting glucose vs A1c
Fasting insulin is one of several ways to read blood sugar, and each answers a different question. If you are not sure which test you were given, start with how to read a blood-sugar result, or step back to the full blood sugar picture.
| Fasting insulin | Fasting glucose | HbA1c | |
|---|---|---|---|
| What it measures | How much insulin it takes to hold glucose normal | Blood sugar at one morning moment | Average blood sugar over about 3 months |
| What it flags first | Insulin resistance, the earliest shift | Glucose problems once compensation fails | Sustained high glucose over weeks |
| Fasting needed | Yes, 8+ hours | Yes, 8+ hours | No |
| Used to diagnose | No, a risk and research marker | Yes | Yes |
| Where it wins | Spotting trouble while glucose still looks normal | A direct, low-cost snapshot | Convenient trend, no fasting required |
For the exact cutoff numbers, lean on the marker pages that own them. A fasting glucose reads a single moment; an HbA1c averages roughly three months, so the two can genuinely disagree.
A fasting glucose of 100 to 125 mg/dL is prediabetes and 126 or higher, confirmed, is diabetes; it is a single morning snapshot after at least 8 hours without food.
An HbA1c of 6.5% or higher is diabetes, 5.7 to 6.4% is prediabetes, and under 5.7% is normal; it is a 3-month average of your blood sugar, weighted toward the last few weeks.
Can insulin resistance be reversed?
Often yes, especially when it is caught early. Insulin resistance is the engine of prediabetes, the reversible zone before type 2 diabetes, and it is both common and mostly silent.
More than 1 in 3 US adults have prediabetes, and over 8 in 10 of them do not know they have it.
The strongest evidence that the trajectory can bend comes from the Diabetes Prevention Program, a randomized trial in people at high risk.
Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk. The lifestyle intervention was more effective than metformin.Diabetes Prevention Program Research Group, NEJM 2002 [[4]]
In the Diabetes Prevention Program, 7% weight loss plus 150 minutes of weekly activity cut progression to type 2 diabetes by 58% over about 3 years.
Metformin is a prescription medicine studied here for diabetes prevention, not a suggestion to start it; whether any medication fits your situation is a decision for your clinician.
Citations
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
- Tabak AG, Jokela M, Akbaraly TN, Kivimaki M, Witte DR, Brunner EJ. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009;373(9682):2215-2221.
- American Diabetes Association. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S27-S49.
- Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393-403.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.
Associations to explore with a clinician, not a diagnosis from a single number.